Robert D. Hawkins - Concepedia

Author

Robert D. Hawkins

Also Known As

Eric R. Kandel, Griffiths, Thomas L., Hawkins, Robert, Hawkins, Robert D, Hawkins, Robert D., Hawkins, Robert E., Hawkins, Robert X. D., Noah Goodman, R D Hawkins, R Hawkins

398

Publications

31K

Citations

H-Index

247

Concepts

All Affiliations

Columbia University New York State Psychiatric Institute Howard Hughes Medical Institute New York Psychoanalytic Society and Institute Stanford University

About

Robert D. Hawkins is an author at Columbia University specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	17	19	1.3K
2	Engineering	9	9	958
3	Business	2	2	55
4	Education	2	2	72
5	Arts	1	1	13

Robert D. Hawkins

144

Publications

27.3K

Citations

H-Index

Page 1

	Year	Citations
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma Robert J. Motzer, Nizar M. Tannir, Osvaldo Arén Frontera, New England Journal of Medicine	2018	4.5K
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma Brian I. Rini, Elizabeth R. Plimack, V.P. Stus, New England Journal of Medicine	2019	3.3K
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma Robert J. Motzer, Thomas E. Hutson, David Cella, New England Journal of Medicine	2013	1.9K
Control of Memory Formation Through Regulated Expression of a CaMKII Transgene Mark Mayford, Mary Elizabeth Bach, Yan-You Huang, Science Regulated ExpressionMolecular RegulationTransgene ExpressionNeurotransmitterMolecular Biology	1996	1.6K
Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Thomas J. O’Dell, Robert D. Hawkins, Eric R. Kandel, Proceedings of the National Academy of Sciences Nitric OxideSynaptic TransmissionNeurotransmitterCell CultureNeurotransmission	1991	1K
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial Brian I. Rini, Thomas Powles, Michael B. Atkins, The Lancet UrologyGenitourinary CancerMedicineBevacizumab Versus SunitinibImmune Checkpoint Inhibitor	2019	988
Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation <i>in vitro</i> and are attenuated by drugs that enhance the cAMP signaling pathway Mary Elizabeth Bach, Mark Barad, Hyeon Son, Proceedings of the National Academy of Sciences	1999	565
Nitric Oxide And Carbon Monoxide Produce Activity-Dependent Long-Term Synaptic Enhancement in Hippocampus Min Zhuo, Scott A. Small, Eric R. Kandel, Science	1993	555
Increased Attention to Spatial Context Increases Both Place Field Stability and Spatial Memory Clifford G. Kentros, Naveen Agnihotri, Samantha Streater, Neuron Spatial ReasoningCognitive ScienceMemoryCognitionProcedural Memory	2004	542
Abolition of Long-Term Stability of New Hippocampal Place Cell Maps by NMDA Receptor Blockade Clifford G. Kentros, Eric L. Hargreaves, Robert D. Hawkins, Science	1998	495

Page 1